logo

QURE

uniQure
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 6
Sell signal 0
stock price surged significantly
consensus rating "Strong Buy"
MACD Golden Cross
Upward Gap
Revenue Beats Expectation
EPS Beats Expectation

Key Stats

--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

About QURE

Uniqure N.V.

A leading gene therapy company that develops innovative treatments for genetic diseases

Biological Technology
01/09/2012
02/05/2014
NASDAQ Stock Exchange
209
12-31
Common stock
Paasheuvelweg 25a, 1105 BP Amsterdam, The Netherlands
--
UniQure N.V. was established as a private limited liability company on January 9, 2012 in accordance with the relevant provisions of the Dutch law. UniQure is a leader in the field of gene therapy and has developed the first and so far only gene therapy product that has received EU regulatory approval. Gene therapy provides long-term and potentially effective benefits to patients with genetic or acquired diseases, either by guiding the expression of therapeutic protein genes or by repairing the expression of deletion proteins through a single management. The company's first product, Glybera, was approved by the European Commission in October 2012 due to its excellent effect on patients with lipoprotein lipase deficiency (LPLD), a potentially life-threatening orphan metabolic disease.

Company Financials

EPS

QURE has released its 2024 Q4 earnings. EPS was reported at -1.49, versus the expected -0.54, missing expectations. The chart below visualizes how QURE has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

QURE has released its 2024 Q4 earnings report, with revenue of 5.22M, reflecting a YoY change of -21.95%, and net profit of -73.26M, showing a YoY change of -0.08%. The Sankey diagram below clearly presents QURE’s revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime